Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Active not recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 2Neoplasms 2Adenocarcinoma 2

Interventions

trametinib 4dabrafenib 4encorafenib 3Oxaliplatin 3zolbetuximab 2selpercatinib 2pembrolizumab 2lenvatinib 2larotrectinib 2dostarlimab 2binimetinib 2Leucovorin 2Fulvestrant 2Fluorouracil 2Cetuximab 2Capecitabine 2trastuzumab deruxtecan 1tepotinib 1telisotuzumab vedotin 1ribociclib 1repotrectinib 1relatlimab 1pralsetinib 1pegaspargase 1niraparib 1blinatumomab 1avelumab 1asparaginase erwinia chrysanthemi recombinant 1adagrasib 1Vemurafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has announcements × Neoplasms × zolbetuximab × Clear all
NCT03504397 2026-05-04

Spotlight

Astellas Pharma Inc

Phase 3 Active not recruiting
565 enrolled 63 charts 1 FDA
Gastrointestinal

Adenocarcinoma, Neoplasms, Stomach Neoplasms

NCT03653507 2026-04-17

GLOW

Astellas Pharma Inc

Phase 3 Active not recruiting
507 enrolled 65 charts 1 FDA
Gastrointestinal

Adenocarcinoma, Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡